MedPath

Community-acquired Pneumonia in Adults in India: A Retrospective Data Analysis Study. Observational Study

Not Applicable
Completed
Conditions
Health Condition 1: J17- Pneumonia in diseases classified elsewhere
Registration Number
CTRI/2023/03/050685
Lead Sponsor
Jehangir Clinical Development Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
1300
Inclusion Criteria

This study will include records of patients =18 years and who:

? have been hospitalized (transferred) from emergency or outpatient

departments to an inpatient ward (inclusive of the intensive care unit [ICU])

during the selected periods of enrollment (01 January 2019 – 31 December

2019, and 01 January 2022 – 30 June 2022).

? have received a diagnosis of lower tract respiratory infection (LTRI)

(clinical diagnosis confirmed by radiology X-ray or computed tomography

[CT] scan), inclusive of influenza and COVID-19 pneumonia (the latter,

relevant for the first half of the year 2022).

? have an LTRI diagnosis that is compatible with a community source of

infection before hospitalization as determined by the participating

investigator

Patients with a diagnosis of LTRI could include the following 3 categories:

a) have newly diagnosed CAP during the study period of enrollment with no

history of CAP before the start of the study period of enrollment

b) have a recurrence during the study period of enrollment, of a CAP that

occurred before the start of the study period of enrollment

The date of first admission to the hospital for the above two patient

categories (a and b) during the study period of enrollment is the index date.

c) have a recurrence of a CAP (defined by a time interval of at least one month

from the previous CAP admission) during the study period of enrollment.

For this category of patients, the date of second admission would be

considered as the index date.

Exclusion Criteria

Not provided

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The aim of this study is to estimate the burden of severe CAP (severe enough to <br/ ><br>cause hospitalization) in adults in India according to initial state of severity,microbiology, and a comprehensive list of risk factors. The study will cover two <br/ ><br>periods, before (year 2019) and during (first half of 2022) the COVID-19 pandemic.Timepoint: The timepoint for the outcome is after data collection. outcomes will be based on data extracted from two observation periods i.e. 2019 and first half of 2022. The timepoint for the outcome is after data collection.
Secondary Outcome Measures
NameTimeMethod
ILTimepoint: NI
© Copyright 2025. All Rights Reserved by MedPath